Astra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reports

1 hour ago 1

Healthcare

Comments
(2)

Abstract concept design of medical facility or hospital

AstraZeneca (AZN) and Eli Lilly (NYSE:LLY) have become the latest leading drugmakers to reconsider their investment options in the U.K. after Merck (MRK) canceled plans for a £1B research center in London, according to multiple reports.

Astra (NASDAQ:AZN) has

Recommended For You

Read Entire Article

Astra, Lilly are latest to reevaluate U.K. investments after Merck’s pullback: reports

Recommended For You

Related

EPA proposed rule to end Greenhouse Gas Reporting Program

Ten-League International receives Nasdaq deficiency letter

Osisko Development files to sell 104.75M common shares for h...

mF International files $700M mixed securities shelf

HUNTINGTONBancshares Incorporated 5.7% DP SH PFD I declares ...

CI Canadian REIT ETF declares CAD 0.0675 dividend

CI Energy Giants Covered Call ETF Common Units (CAD Hedged) ...

Multi Ways announces pricing of $1.485 million registered di...

Volato Group files $100M mixed securities shelf

Omega Flex declares $0.34 dividend

CI Energy Giants Covered Call ETF Common Units (USD Hedged) ...

CI Morningstar National Bank Québec Index ETF Common declare...

CI U.S. MidCap Dividend Index ETF declares $0.3172 dividend

Armada Hoffler Properties declares $0.14 dividend

CI U.S. & Canada Lifeco Covered Call ETF (Hedged Common Unit...

Western Alliance announces $300M share repurchase program

Stellantis shelves full-size BEV truck, renames Ramcharger a...

Starbucks trades in red for eight straight sessions

Corteva gains on report it's exploring a breakup

Ray Dalio calls for wealth ‘redistribution policy’ when AI a...

Trending

Popular

فیلم/ پارلمان نپال به تصرف معترضان درآمد

نشست پنج روز پیش تیم ایرانی با اعضای هدف قرار گرفته حماس در ...